175 related articles for article (PubMed ID: 15258776)
21. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
Ladd BS; Solomon SD; Bressler NM; Bressler SB
Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults.
Rogers AH; Duker JS; Nichols N; Baker BJ
Ophthalmology; 2003 Jul; 110(7):1315-20. PubMed ID: 12867384
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
[TBL] [Abstract][Full Text] [Related]
24. Outcome of photodynamic therapy in choroidal neovascularization due to pathologic myopia and related factors.
Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
Int Ophthalmol; 2012 Apr; 32(2):119-25. PubMed ID: 22350116
[TBL] [Abstract][Full Text] [Related]
25. Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: results from a randomized pilot study.
Costa RA; Williams GA;
Retina; 2006 Sep; 26(7):757-64. PubMed ID: 16963848
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy in subfoveal and juxtafoveal myopic choroidal neovascularization: a 10-year retrospective analysis.
Varano M; Iacono P; Giorno P; Chiaravalloti A; Parravano M
Ophthalmologica; 2014; 231(4):204-10. PubMed ID: 24481122
[TBL] [Abstract][Full Text] [Related]
27. Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.
Rinaldi M; Semeraro F; Chiosi F; Russo A; Romano MR; Savastano MC; dell'Omo R; Costagliola C
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):529-539. PubMed ID: 27680013
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia.
Bandello F; Lanzetta P; Battaglia Parodi M; Roman-Pognuz D; Saviano S; Ravalico G
Graefes Arch Clin Exp Ophthalmol; 2003 Jul; 241(7):567-570. PubMed ID: 12819976
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes.
Cohen SY; Bulik A; Dubois L; Quentel G
Am J Ophthalmol; 2003 Aug; 136(2):371-4. PubMed ID: 12888071
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization.
Yoon JU; Byun YJ; Koh HJ
Retina; 2010 Mar; 30(3):418-24. PubMed ID: 20094012
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopia.
Schnurrbusch UE; Jochmann C; Wiedemann P; Wolf S
Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):829-33. PubMed ID: 16133036
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
[TBL] [Abstract][Full Text] [Related]
33. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
34. Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization.
Tan CS; Chew MC; Lim TH
Eye (Lond); 2014 Jan; 28(1):17-22. PubMed ID: 24051405
[TBL] [Abstract][Full Text] [Related]
35. Retinal pigment epithelial marginal retraction after photodynamic therapy for choroidal neovascularization in pathologic myopia.
Pece A; Isola V
Eur J Ophthalmol; 2008; 18(5):841-4. PubMed ID: 18850572
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
37. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases.
Wachtlin J; Heimann H; Behme T; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2003 Nov; 241(11):899-906. PubMed ID: 14556077
[TBL] [Abstract][Full Text] [Related]
38. [Photodynamic therapy of subfoveal choroidal neovascularization].
Georgijević A; Tomić Z
Srp Arh Celok Lek; 2007; 135 11-12():629-34. PubMed ID: 18368902
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease.
Nowilaty SR; Bouhaimed M;
Br J Ophthalmol; 2006 Aug; 90(8):982-6. PubMed ID: 16687455
[TBL] [Abstract][Full Text] [Related]
40. Long-term results of photodynamic therapy for subfoveal choroidal neovascularization with pathologic myopia.
Giansanti F; Virgili G; Donati MC; Giuntoli M; Pieretti G; Abbruzzese G; Menchini U
Retina; 2012 Sep; 32(8):1547-52. PubMed ID: 22481476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
